![[ Visit Client Website ]](images/banner.jpg)
Friday, March 4, 2016
7:00 AM-1:45 PM
1012
FIT Symposium TICKETED
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 5
0.00 CME/CE
Symposium
Moderator:
Becky J. Buelow , MD
Learning Objectives:
- Discuss the mechanisms of asthma
- Describe the advances of treatment in childhood asthma
- Discuss the biologic treatments of asthma and how these relate to different asthma phenotypes
4:00 PM-5:15 PM
1801
What Can Implementation Research Teach Us About the Management of Asthma?
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Moderator:
Giselle Mosnaim , MD MS FAAAAI
Learning Objectives:
- Describe and define the role of implementation research to improvement of asthma outcomes
- Identify the methodologies for conducting implementation research in asthma
- Identify new areas for implementation research in asthma
1802
Management of Atopic Dermatitis: What's New?
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
Kelly D. Stone , MD PhD FAAAAI
Learning Objectives:
- Discuss the role of skin microbiome in atopic dermatitis
- Discuss patient education for atopic dermatitis
- Discuss possible therapeutic consequences owing to new insights into the pathogenesis of atopic dermatitis
1803
Automating Pollen Identification/NAB
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Symposium
Moderator:
Dennis K. Ledford , MD FAAAAI
Learning Objectives:
- Discuss current laboratory techniques which could permit automated aeroallergen determinations
- Review the problems associated with collecting samples for automated aeroallergen assessments
- Identify and provide an up-to-date scientific analysis of how soon such techniques will be available to the community
1804
B-Regulatory Cells: No Longer Playing Second Fiddle to T Regs
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Symposium
Moderator:
Cezmi A. Akdis , MD FAAAAI
Learning Objectives:
- Discuss the prominent role B cells that express PD-L1 occupy in the regulation of humoral immune responses
- Describe the settings in which B lymphocytes express IL-10, providing these B cells with potent ability to regulate both innate and adaptive immune responses
- Discuss settings in which B lymphocytes may play important roles as modulators of all responses in organ transplantation
1805
Secondary Immune Deficiencies (Non-HIV)
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
Christina L. Nance , PhD
Learning Objectives:
- Discuss secondary immunodeficiency due to underlying disease states, environmental exposures and other causes
- Discuss underlying mechanisms and sequelae of the immune dysfunction of secondary immunodeficiencies
1806
Non-IgE-Mediated Gastrointestinal Food Allergies in Children and Adults
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Symposium
Moderator:
Kirsi M. Jarvinen-Seppo , MD PhD FAAAAI
Learning Objectives:
- Describe immune responses to foods in the GI tract
- Describe manifestations, diagnosis and management of food protein-induced enterocolitis syndrome (FPIES) with emphasis on the evolution of systemic IgE immune response to foods and implications for management
- Describe the continuum of immune responses to wheat from childhood to adulthood and potential therapeutic targets
1807
Allergy in Schools: Keeping Kids Healthy and Safe
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Carla M. Davis , MD FAAAAI
Learning Objectives:
- Discuss and guide management of asthma in schools
- Discuss and guide management of anaphylaxis in schools
- Describe management of food allergy in schools
1808
Microbial Regulation of Allergic Airway Inflammation: Lessons from the AADCRC
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 502B
1.25 CME/CE
Symposium
Moderator:
R. Stokes Peebles Jr. , MD FAAAAI
Learning Objectives:
- Discuss and define the factors that regulate severity of illness to rhinovirus infection
- Identify the mechanisms by which CARDS toxin induces allergic airway inflammation
- Describe how virus infection regulates airway epithelial cell function
Saturday, March 5, 2016
10:45 AM-12:00 PM
2301
World Allergy Forum: Role of Intolerance in Food Allergy
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, South Exhibit Hall G
1.25 CME/CE
Symposium
Primary Moderators:
Robert F. Lemanske Jr. , MD FAAAAI
Mario Sánchez-Borges , MD FAAAAI
Mario Sánchez-Borges , MD FAAAAI
Learning Objectives:
- Identify the worldwide patterns associated with food intolerances
- Describe the regimens used for tolerance inductions
- Describe new therapeutic options in prevention of food allergy worldwide
2302
Lessons from Performing Guideline-Driven, Evidence-Based Asthma Interventions in the Real World: Who Benefits?
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
Anne Markus , JD, PhD, MHS
Learning Objectives:
- Describe how to promote effective adaptation when developing an evidence-based intervention, such as ongoing dialogue between researchers and the target healthcare setting to respond to the needs of the clinic while monitoring fidelity to the intervention
- Discuss if evidence-based interventions remain effective when translated into populations and healthcare settings that differ from the parent trials, and identify what components may be needed to retain efficacy
- Identify and assess if evidence-based asthma interventions are cost effective when translated across several different healthcare settings with various insurance providers, and identify what elements payers are interested in supporting for potential intervention sustainability
2303
New Molecular Breakthroughs in the Study of Immunoglobulin E
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Symposium
Moderator:
Donald W. Macglashan , MD PhD
Learning Objectives:
- Describe the molecular mechanisms of IgE production and activation of mast cells
- Discuss new opportunities for development of drugs that affect mast cell function
- Discuss the nature of post-translational modifications that regulate the activities of IgE
2304
Epithelium and Innate Immune Responses: Airways and Skin
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Symposium
Moderator:
Robert P. Schleimer , PhD FAAAAI
Learning Objectives:
- Discuss that bitter and sweet taste receptors are present in multiple anatomic compartments and can serve as innate immune system sentinels
- Discuss the multiple roles that epithelial cells in the skin serve in host defense and regulators of inflammation
- Discuss that epithelial cells in the lung produce many secreted molecules that regulate innate and adaptive immune responses
2305
Epigenetic Mechanisms in Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
Kathleen C. Barnes , PhD FAAAAI
Learning Objectives:
- Discuss epigenetic mechanisms that regulate allergic disease
- Describe the difference between gene-environment interaction and epigenetics
- Discuss gene-environment interactions that regulate cytokine responses
2306
Managing Stinging Insect Allergy in the 21st Century
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Moderator:
Dennis K. Ledford , MD FAAAAI
Learning Objectives:
- Describe the mechanism of tolerance development during venom immunotherapy
- Assess the indications for initiation and discontinuation of venom immunotherapy
- Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders
2307
What Do I Do With These Abnormal Newborn Screening Results?
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Lisa J. Kobrynski , MD MPH FAAAAI
Learning Objectives:
- Identify the incidence of SCID and survival outcomes after implementation of newborn screening programs
- Identify idiopathic lymphopenia, dilemmas and strategies for management
- Discuss various transplantation protocols and new experimental treatment options for SCID
2308
NHLBI's Clinical Asthma Research Network (AsthmaNet)'s Approach to Key Asthma Questions in Children and Adults
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Concourse Hall Room 152
1.25 CME/CE
Symposium
Moderator:
James Kiley , PhD
Learning Objectives:
- Discuss individualized long-term controller therapy in toddlers with asthma
- Discuss the effect of acetaminophen versus ibuprofen on asthma exacerbations in children with asthma
- Discuss the potential role of airway microbiome on the effect of ICS on adult asthma
2311
Allied Health: Comorbidities of Atopic Dermatitis
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 407
1.25 CME/CE
Symposium
Moderator:
Sally A. Noone , RN MSN
Learning Objectives:
- Describe the systemic comorbidities associated with atopic dermatitis
- Identify the atopic dermatitis patients at highest risk for systemic comorbidities
- Discuss treatment considerations for atopic dermatitis and their impact on associated comorbidities
2312
Allied Health: Cutting Edge: Health Related Quality of Life and Allergy Disease
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Symposium
Moderator:
Scott H. Sicherer , MD FAAAAI
Learning Objectives:
- Discuss the quality of life implications of various food allergy management approaches (including Oral Immunotherapy)
- Identify the role of the dietitian in assisting patients in maintaining or improving quality of life
12:30 PM-1:30 PM
2554
Imaging Immunity in Health and Disease
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Theatre (Room 411)
1.00 CME/CE
Symposium
Moderator:
William T. Shearer , MD PhD FAAAAI
Learning Objectives:
- Discuss how imaging can be utilized in allergy/immunology
- Discuss how imaging can be utilized to help with diagnosis and management of primary immunodeficiency
Sunday, March 6, 2016
7:00 AM-8:00 AM
3050
Are LABAs Safe in Asthma? Are They Effective?
Session Details
Session Details
Sunday, March 6, 2016: 7:00 AM-8:00 AM
Convention Center, Level One, Petree Hall D
1.00 CME/CE
Symposium
Moderator:
Stanley J. Szefler , MD FAAAAI
Learning Objectives:
- Review treatment positioning of LABA in asthma therapy and safety concerns
- Report on one segment of FDA LABA safety trials
- Discuss how to best use LABA in asthma
10:45 AM-12:00 PM
3301
EAACI: Managing Allergy at the Frontline
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Primary Moderators:
Maria Antonella Muraro , MD PhD
Ioana O. Agache , CME
Ioana O. Agache , CME
Learning Objectives:
- Discuss the role of PI-3 kinase defects in viral susceptibilit
- Discuss presentations and causes of NK cell deficiency
- Identify defects in innate immune function that lead to severe influenza infections
3302
T Cell Determination Heterogeneity and Hijacking in Allergic Disease
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
David D. Chaplin , MD PhD FAAAAI
Learning Objectives:
- Recognize unique functions of memory T Cells in allergic disease
- Identify the extent of plasticity in differentiated T Cell lineages and implications in allergic disease
- Identify heterogeneity of T Cell differentiation pathways and implications in allergic disease
3303
Difficult Viral Infections Due to Defects in Innate Immunity
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Symposium
Moderator:
Lisa R. Forbes , MD
Learning Objectives:
- Discuss the role of PI-3 kinase defects in viral susceptibility
- Discuss presentations and causes of NK cell deficiency
- Identify defects in innate immune function that lead to severe influenza infections
3304
Emerging and Current Diagnostics and Therapies for Eosinophilic Esophagitis
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
John J. Lee , MD
Learning Objectives:
- Discuss current and emerging therapies as well as biomarkers in patients with EOE
3305
Severe Asthma in Children: From Mechanisms to Disease Modification
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Symposium
Moderator:
To be announced.
Learning Objectives:
- Describe the frequency and common features of severe asthma in children
- Identify common underlying mechanisms of severe asthma in children
- Discuss the efficacy of omalizumab and the potential for disease modification in children
3306
Using SCIT vs. SLIT to Modify Allergic Disease
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Linda Cox , MD FAAAAI
Learning Objectives:
- Discuss the latest data on the efficacy and safety of SCIT compared to SLIT for grass pollen allergy
- Identify several newly discovered biomarkers for AIT efficacy
- Discuss and explain safety and adherence issues of SLIT and SCIT and utilize resources to try to overcome them
3307
New Strategies for the Prevention of Allergic Diseases
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502B
1.25 CME/CE
Symposium
Moderator:
Désirée E.S. Larenas Linnemann , MD FAAAAI
Learning Objectives:
- Discuss the more in-depth consequences and public health implications of data presented in the LEAP study
- Describe trials to detect the preventive effects of allergen immunotherapy
- Identify the latest data concerning stimulation of the innate immune system in allergic and asthma inflammation
3311
Allied Health: Determining the Bioequivalence of Generic Inhalers
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Symposium
Moderator:
Anne E. Borgmeyer , DNP RN CPNP AE-C
Learning Objectives:
- Identify the differences in regulatory requirements for inhalers
- Discuss the different methods of determining bioavailability of inhalers
- Describe the pharmacokinetic studies of inhalers
3312
Allied Health: Advocacy for Patients with Primary Immune Deficiency Disease (PIDD)
Session Details
Session Details
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Symposium
Moderator:
Stephen J. McGeady , MD FAAAAI
Learning Objectives:
- Discuss the approaches to use to assist PIDD patients to be a self-advocate
- Discuss techniques to support patients to manage the challenges of living with a chronic illness
Monday, March 7, 2016
10:45 AM-12:00 PM
4301
Novel Endotypes of Asthma: Lessons from the AADCRC
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Moderator:
John V. Fahy , MD
Learning Objectives:
- Describe Th2 High asthma phenotype and treatment
- Describe presentation and management of AERD
- Discuss the role of pollution in asthma pathogenesis, from mechanism to management
4302
Environmental and Lifestyle Influences on Childhood Asthma
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
Gang Dong , MD PhD
Learning Objectives:
- List the factors contributing to asthma development in pre-schoolers
- Describe the immunologic basis for early life sensitization which increases asthma risk
- Describe microbiome-virus interrelationships in asthma and strategies for asthma prevention in childhood
4303
State-of-the-Art: Update from the AADCRC Food Allergy Research Centers
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Symposium
Moderator:
Brian P. Vickery , MD FAAAAI
Learning Objectives:
- Describe the T Cell responses during food immunotherapy
- Describe the approaches to profiling food allergic processes
- Describe the B and T lymphocyte surrogates of tolerance
4304
Phospholipases A2 and Lipid Mediators in the Pathogenesis of Asthma
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Symposium
Moderator:
Joshua A. Boyce , MD FAAAAI
Learning Objectives:
- Describe how lipids are major mediators of asthma
- Discuss the role of phospholipases A2, enzymes for the generation of lipids
- Describe the role of innate immune cells that produce these enzymes and initiate asthma pathogenesis in humans
4305
Immunologic Insights into Environmental Triggers of Asthma
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
John W. Steinke , PhD FAAAAI
Learning Objectives:
- Identify how environmental triggers of asthma can promote frequent exacerbation phenotypes
- Discuss new immunologic mechanisms by which common environmental triggers promote asthma
- Discuss how environmental allergens can act as immunomodulators independent of their antigenicity
4306
Allergen Immunotherapy: From Mechanisms to Biomarkers
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Symposium
Moderator:
Stephen R. Durham , MA MD FRCP
Learning Objectives:
- Describe novel local and systemic responses following allergen immunotherapy
- Discuss how Th2A cells can be used to monitor tolerance induction during allergen immunotherapy
- Discuss how molecular allergology can be utilized to select patients and monitor the effects allergen immunotherapy
4307
Surviving and Optimizing ICD-10
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Melinda M. Rathkopf , MD FAAAAI
Learning Objectives:
- Discuss the update on ICD-10 and its impact since the October 2015 go live date
- Discuss common problems and identify strategies to optimize ICD-10 in clinical practice
- Discuss difficult coding cases from attendees own clinical practices
4308
The Spectrum of Angioedema: Bench to Bedside
Session Details
Session Details
Monday, March 7, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502B
1.25 CME/CE
Symposium
Moderator:
Paula J. Busse , MD FAAAAI
Learning Objectives:
- Discuss the mechanisms of angioedema in nonhistaminergic angioedema including mediators such as histamine, leukotrienes and bradykinin
- Discuss the mechanism of angioedema with NSIADS